Shandong Xinhua Pharmaceutical Company Limited
HKSE: 0719.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Tongqing He
- Employees
- 7,296
- Headquarters
- Zibo, China
- IPO year
- 1996
- Market cap
- HK$9.4B
- Website
- https://www.xhzy.com
Loading 0719…
Loading profile data…Frequently asked questions about 0719
What does Shandong Xinhua Pharmaceutical Company Limited (0719.HK) do?
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparat...
Where does 0719.HK trade?
Shandong Xinhua Pharmaceutical Company Limited (0719.HK) trades on the Hong Kong Stock Exchange.
What sector is 0719.HK in?
Shandong Xinhua Pharmaceutical Company Limited (0719.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shandong Xinhua Pharmaceutical Company Limited?
Tongqing He is the chief executive officer of Shandong Xinhua Pharmaceutical Company Limited (0719.HK).
Where is Shandong Xinhua Pharmaceutical Company Limited headquartered?
Shandong Xinhua Pharmaceutical Company Limited is headquartered in China.
Does 0719.HK pay a dividend?
Yes — Shandong Xinhua Pharmaceutical Company Limited (0719.HK) paid a trailing twelve-month dividend of HKD 0.57 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0719.HK go public?
Shandong Xinhua Pharmaceutical Company Limited (0719.HK) completed its initial public offering in 1996.